Profile data is unavailable for this security.
About the company
ANGLE plc is a United Kingdom-based liquid biopsy company. The Company is engaged in the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy-non-invasive cancer diagnostics. Its platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for highly multiplexed analysis of nucleic acids and proteins. Its Parsortix PC1 Clinical system captures and harvests circulating CTCs from metastatic breast cancer patients blood for subsequent, user-validated analysis. The Parsortix PC1 Clinical System is a liquid biopsy technology. Its labs in Guildford provide specialist CTC enrichment and analysis services to support translational research studies and pharmaceutical trials. It has developed the Parsortix system, including instruments and one-time use cassettes that can be sold to third-party laboratories for their use in research, pharmaceutical development, or clinical use.
- Revenue in GBP (TTM)1.82m
- Net income in GBP-22.28m
- Incorporated2003
- Employees170.00
- LocationAngle PLCThe Surrey Research Park, 10 Nugent RoadGUILDFORD GU2 7AFUnited KingdomGBR
- Phone+44 148 334 3434
- Fax+44 148 368 5836
- Websitehttps://www.angleplc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polarean Imaging PLC | 273.89k | -11.51m | 8.43m | 28.00 | -- | 0.838 | -- | 30.76 | -0.054 | -0.054 | 0.0013 | 0.0465 | 0.0153 | 0.1134 | 0.1971 | 9,781.90 | -64.22 | -59.80 | -72.25 | -68.38 | 39.65 | 59.23 | -4,201.18 | -574.07 | 4.66 | -- | 0.0225 | -- | -12.86 | -3.54 | 0.7877 | -- | 30.60 | -- |
| Genedrive PLC | 272.00k | -5.00m | 8.77m | 43.00 | -- | 4.98 | -- | 32.23 | -0.0509 | -0.0509 | 0.0028 | 0.0123 | 0.0658 | -- | 1.60 | 6,325.58 | -120.84 | -97.55 | -197.86 | -128.51 | -- | -- | -1,837.50 | -797.03 | 1.36 | -7.49 | 0.0789 | -- | 12.24 | -50.95 | -10.16 | -- | 16.72 | -- |
| Windar Photonics PLC | 2.39m | -592.68k | 38.16m | 23.00 | -- | 499.31 | -- | 15.99 | -0.0105 | -0.0105 | 0.0421 | 0.0009 | 0.8292 | 1.48 | 7.21 | 103,749.80 | -20.59 | -38.01 | -86.08 | -73.57 | 53.65 | 52.25 | -24.84 | -88.12 | 0.7068 | -1.96 | 0.9687 | -- | 236.01 | -3.49 | 4.74 | -- | 1.40 | -- |
| ANGLE plc | 1.82m | -22.28m | 40.39m | 170.00 | -- | 1.26 | -- | 22.22 | -0.086 | -0.086 | 0.007 | 0.1231 | 0.0444 | 0.3624 | 1.11 | 10,694.12 | -54.36 | -- | -60.65 | -- | 60.23 | -- | -1,225.41 | -- | 6.93 | -339.93 | 0.1248 | -- | 2.76 | -- | -44.46 | -- | -- | -- |
| Kromek Group PLC | 17.62m | -4.10m | 44.87m | 173.00 | -- | 0.8881 | 86.79 | 2.55 | -0.0077 | -0.0077 | 0.035 | 0.0788 | 0.262 | 0.68 | 2.65 | 101,843.90 | -6.09 | -10.06 | -7.33 | -12.21 | 57.01 | 50.62 | -23.25 | -49.80 | 0.9939 | -2.43 | 0.2208 | -- | 43.58 | 7.88 | -24.03 | -- | 3.86 | -- |
| Water Intelligence PLC | 59.73m | 3.22m | 56.49m | 436.00 | 18.26 | 1.22 | 8.14 | 0.9458 | 0.1778 | 0.1778 | 3.27 | 2.67 | 0.7706 | 13.51 | 5.94 | 136,986.20 | 4.38 | 6.73 | 5.31 | 8.46 | 86.04 | 81.69 | 5.69 | 6.99 | 1.88 | 6.47 | 0.2685 | 0.00 | 30.78 | 32.28 | -38.13 | 31.32 | 22.00 | -- |
| EKF Diagnostics Holdings PLC | 52.61m | 2.35m | 125.91m | 356.00 | 53.57 | 1.88 | 14.81 | 2.39 | 0.0052 | 0.0052 | 0.1159 | 0.1479 | 0.6184 | 3.10 | 6.00 | -- | 3.21 | 5.20 | 3.73 | 6.13 | 46.45 | 50.04 | 5.19 | 7.91 | 1.77 | -- | 0.0567 | -- | -21.05 | 4.34 | 123.28 | -25.30 | 30.37 | -- |
| Strix Group PLC | 144.59m | 16.20m | 165.13m | 850.00 | 10.37 | 3.90 | 6.64 | 1.14 | 0.0728 | 0.0728 | 0.6509 | 0.1938 | 0.717 | 3.29 | 6.14 | -- | 8.01 | 15.23 | 10.71 | 21.00 | 39.55 | 39.99 | 11.18 | 17.63 | 1.03 | 3.00 | 0.7199 | -- | 35.23 | 9.05 | -3.50 | -6.92 | 1.04 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Global Frontier Investments LLCas of 08 Feb 2024 | 16.87m | 6.47% |
| Hargreaves Lansdown Asset Management Ltd.as of 08 Feb 2024 | 9.53m | 3.66% |
| Baillie Gifford & Co.as of 23 Jun 2023 | 8.05m | 3.09% |
| Chelverton Asset Management Ltd.as of 30 Jun 2023 | 7.50m | 2.88% |
| Aegon Asset Management UK PLCas of 06 Jan 2024 | 5.29m | 2.03% |
| IG Markets Ltd.as of 08 Feb 2024 | 3.43m | 1.32% |
| Evelyn Partners Investment Management LLPas of 08 Feb 2024 | 3.30m | 1.27% |
| Unicorn Asset Management Ltd.as of 08 Feb 2024 | 2.77m | 1.06% |
| Canaccord Genuity Wealth Ltd.as of 30 Sep 2023 | 2.18m | 0.84% |
| United Nations Joint Staff Pension Fundas of 08 Feb 2024 | 2.04m | 0.78% |
